{"name":"Theragnostics Ltd","slug":"theragnostics-ltd","ticker":"","exchange":"","domain":"theragnostics.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNeVVKdHd4eTJxeTFyUWU5OXdyRV9jbXE5ZVZZaGRLSXlpdUQ2MFlqVjZwQjFFY3YtanIxZk9wQmhqYTlLM1RrdzVxWU1KVGNVMkQ5RmNnaVhMemlUUE5yMEN4TWdKN3ZfLXpnendQN2VDQjZ6YVJ2ZC1QVkFnRU43WjB3LU8zSk1sYjJaemR3aWtvV2FFRzhLOXlnRGVPZw?oc=5","date":"2026-02-06","type":"pipeline","source":"mskcc.org","summary":"New Technology May Improve Treatment of Deadly Lung and Prostate Cancers - mskcc.org","headline":"New Technology May Improve Treatment of Deadly Lung and Prostate Cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNeG8wUC1uYXNRUTlZREVrRjdMRFdVWTloZm1kbWJxRnlUVjRsdU92VUplNUt2UHVYUDZha0FRVUZ4bW13V2VTVXE2SjJMSWZuNFl5YmNTUERsNUNSZDZZVURaR2pDZ0Rmald5amQ5YlNOdURvZzFITlNQTndtNUZxZGUta0NnTTEtVzdTVXN6QmdUVmttQ2lGdFlvRjJYN1RqYnJ6d1dicjA?oc=5","date":"2025-12-16","type":"trial","source":"BioWorld News","summary":"Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints - BioWorld News","headline":"Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQejNFUE53M0d3bVR1SG9aLS1IZEY4OXl1Q1BNY182M3JzZ0dCN016Y2ZuUFliYUJzNU9FR3FocXFjaE1xckRPRjBqWGNuSm05SXJ6NEd0TDVJbUdvZV9VMWE5bjZDU04xVFZIN0RmM0k4VkhuYVoyYTJCMkszTFZQR2JIYjctVHdIQmxBVUpMSzRFX0ZZMzJFeU1Bd0RPdHV5RFJ0alVZUUtqNnNv?oc=5","date":"2025-09-30","type":"deal","source":"smallcaps.com.au","summary":"Starpharma and Radiopharm Theranostics Partner to Develop Novel Radiotherapy Asset - smallcaps.com.au","headline":"Starpharma and Radiopharm Theranostics Partner to Develop Novel Radiotherapy Asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNbW1XY3pFamxBYW9sc1dxSWhsZkFmOHlMNUhVNHc5SVdwa18zSDdwZWJBaDBZUFZBX0NNQ3BfNlluaU9JN1RTbldVX3phLXZVZl9zTF9DN1BHMWEzWDdGODFGR2dVUWNIT2Q1MnRCYXRVdXFLMlpRT2FJWjUyaWp3aEtBTzNrWkR4a2dlTlNWUUNkOVplX01ZMzcwblJYYUlSOWZOTXZPM19NR2s4Um9YOVpPeHM2NC1qOGtz?oc=5","date":"2025-09-30","type":"pipeline","source":"The Motley Fool Australia","summary":"This biotechnology stock just ticked over 100% gains for the month on more good news - The Motley Fool Australia","headline":"This biotechnology stock just ticked over 100% gains for the month on more good news","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQVkNPQ0lZLW1NbDVlcXlVNlNTSkpGbmFNRHZtRkNLbHdoSjFBcWVoSTctblBFR1NudUR2X04zbkxpY01VUkM5dXdLSEczWHJIOVZWSW1UODRLYmpWN2xuaEMzTGxnY1VuRXJqdVo1ZXEtY0wwdl9HRFA4QVdlVWYycEYxS0dSN25VUXh4b01VeDdSQkdKaHJRcFpEZ0dXTUU?oc=5","date":"2025-01-28","type":"deal","source":"Contract Pharma","summary":"Lantheus Holdings to Acquire Evergreen Theragnostics - Contract Pharma","headline":"Lantheus Holdings to Acquire Evergreen Theragnostics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNY0lKTjZEZjVCSEFKNFZScFlNazlsc2VTOTN3am1UOGFCNlR0T0ttT1d0eFIyaUpoZm1LYUJ0dWhUOEpUQ211cEJBNl9wOGZFZ2VjZ3drYmNJNXZEYTNMR0E0T3ZiWEJlNmNPVVBsNGFBcFo4Q2ttRV9ZNHZ0MDhwQlg1a1l5RTF4QmlXcFBVX3F4c3hJcXhZcUNGUlRSdXBvOUhrMzh1dVVJQ0hUVkNTeUZBSQ?oc=5","date":"2025-01-28","type":"pipeline","source":"Fierce Pharma","summary":"Lantheus lays out $250M+ to get its hands on radiopharma developer and CDMO Evergreen - Fierce Pharma","headline":"Lantheus lays out $250M+ to get its hands on radiopharma developer and CDMO Evergreen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOekljUkdhTlN4TlJhRkJlbWo0X0NKb1Zpa2ZCdUczcUZad2lPYjF3UmVfa0R4cGRBSzlscUN1V0hYUmEwRVpvWEV3c2d2Vy1zYkdCdVkyOC10Y1AzaWVHX2xJU0x0cWJ3VURjMDBBeS16QVlGemJzenBrNjBIZmpjMktJMW5EWURWT2lWcGtqc2NhaHJqdmV5S2YzSXJ3aUItWDcwZjBoM3h0U1lUUGtEcGdzTUZwOHpVVE8taHhWa3E5Z0Z0eS1lY0E5UWl1QQ?oc=5","date":"2024-09-30","type":"pipeline","source":"Pharmaceutical Technology","summary":"Evergreen Theragnostics Radiopharmaceutical Manufacturing Facility, New Jersey, US - Pharmaceutical Technology","headline":"Evergreen Theragnostics Radiopharmaceutical Manufacturing Facility, New Jersey, US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1sZklIWE1hcmhZOVlXT1F1Y1pIMmtITE5XTUQzNFJSSG9tRDV4bm9JWlJsVUo3a2ZIZXRWM1J6TnlyekRWTWtUMExsSXNFS0F4NDVwbl9ZRWkwNnEyRm9UM2U4X2FXczN4Smc?oc=5","date":"2024-06-01","type":"pipeline","source":"jnm.snmjournals.org","summary":"A highly potent FAP-targeting peptide for theranostics: production, validation and first in human experience with Ga-68 and Lu-177 3BP-3940 - jnm.snmjournals.org","headline":"A highly potent FAP-targeting peptide for theranostics: production, validation and first in human experience with Ga-68 ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxORndockg0LXJNeUQtSVJHZS1jX3U1bmp6Z3Z2YUxqN2lsQm40NXc2VDZTQWt6ZnFrUGQxQjc2d3NaZW12WC1FRTQwLTFkMGMzRkVrNzJGaWptNHh5dUgwMXJhZldidl9UX2licWZ2RTVYTDdUNnljLTlPVmhQV05Lb0RPOEhSdjJfcFZ0YkwwZElhTDBZQmdCUWQ3QVNFQVNmVTM3MTV5ZkEyMHBKTWkzLTRUNDRIUEMxRjNWN3VWdUpGbmttdFRaRkZmNk5aZExwVmkzSWRXLUtTamxYX3A1NW5oaDhRcUIyUTRrSHFfMmhEWlMyYy1NbTRHaW1TTi1lSXVhUmpycTBad0ZiS0dvd0JkQ3lzRW1pZzJKU3JyWU1nTTBLNl9oa3V6cHZIZTJiNzV5ZmJZWUtSdTdrZmstWW10Rkl2ZDA?oc=5","date":"2024-04-16","type":"pipeline","source":"BioSpace","summary":"Evergreen Theragnostics Completes $26M Capital Raise to Advance Novel Radiopharmaceutical Pipeline into the Clinic, Prepare for First Commercial Product Launch, and Expand Industry-Leading CDMO Servic","headline":"Evergreen Theragnostics Completes $26M Capital Raise to Advance Novel Radiopharmaceutical Pipeline into the Clinic, Prep","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-06-23","type":"regulatory","source":"PR Newswire","summary":"Jubilant Radiopharma and Evergreen Theragnostics Announce Collaboration for the Sale and Distribution of Neuroendocrine Tumor Diagnostic OCTEVY™, (Kit for Preparation of Ga 68 DOTATOC Injection), pend","headline":"Jubilant Radiopharma and Evergreen Theragnostics Announce Collaboration for the Sale and Distribution of Neuroendocrine ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQWmxHYW9KODZqME9aVENZOC1SS2VzbFBxZXZvelRGcUJGRmN3eHQ5LUVzNDNjYTZlNDZqYlNLNE01SWZBVHhPdkN0VnUydnF3S05hbkdDaDlUQTNnejIyUk1xSFBXOFQxZEdKclZaM0hrN1pSSFByVTg0NC1xM1Q0UE51V0xTVlZMWEt6YVlleHgtajdkbTVwbmNHaW5GYjFfanM5Qzh1OGhvMmY4NGlXODVnODZzR3RH?oc=5","date":"2023-06-01","type":"pipeline","source":"Fierce Biotech","summary":"Ariceum snaps up fellow European biotech Theragnostics to bolster radiopharma efforts - Fierce Biotech","headline":"Ariceum snaps up fellow European biotech Theragnostics to bolster radiopharma efforts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNUkVtM0NpRjVpUE15SU5icWtzUDFUeEc3Q2x5Rkg2VVdIb1oycmxvcVVqb1N0c2Znam1oVWN1SjU3Zlh4Tkd0NjRyeUZXYTdQZjMzY1p3bi1tLXB2MXpFZlM1ejVlMVcycjRGcE1tTHhVeVBsaWROd0hLdHpJaFFfSG44TjAyR2JlNEVpeGl4SDAyMnFYWll5Y3BESQ?oc=5","date":"2019-09-05","type":"pipeline","source":"PharmaTimes","summary":"AstraZeneca, Theragnostics sign PARPi development agreement - PharmaTimes","headline":"AstraZeneca, Theragnostics sign PARPi development agreement","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}